Multiple Myeloma Autologous Stem Cell Transplant

Autologous stem cell transplant multiple myeloma time factors abstract as multiple myeloma mm treatments evolve frequent updates are required to monitor the long term effect of changes in approach.

Multiple myeloma autologous stem cell transplant.

The widespread use of high dose therapy and autologous stem cell transplantation asct as well as the introduction of novel agents have significantly improved outcomes in multiple myeloma mm enabling long term survival. A stem cell transplant in combination with high dose chemotherapy is a treatment option that offers a chance for durable remission for people with multiple myeloma. We here analyze factors influencing survival in 865 newly diagnosed mm patien. It can be a strong weapon in your fight against multiple myeloma.

It isn t a cure but compared to chemotherapy alone a. A stem cell transplant replaces unhealthy blood cells with healthy ones. In a stem cell transplant the patient gets high dose chemotherapy to kill the cells in the bone marrow. Autologous and allogeneic stem cell transplants.

Then the patient receives new healthy blood forming stem cells. When stem cell transplants were first developed the new stem cells came from bone marrow and so this was known as a bone marrow. Autologous stem cell transplant or infusion.